Validation of the novel Eosinophilic Esophagitis Impact Questionnaire
Eilish McCann(Regeneron (United States)), Siddhesh Kamat(Regeneron (United States)), Jonathan M. Spergel(University of Pennsylvania), Tara Symonds(Pfizer (United Kingdom)), Andrew Yaworsky(Adelphi Laboratory Center), Xian Sun(Regeneron (United States)), Mirna Chehade(Icahn School of Medicine at Mount Sinai), Jonathan Stokes(Adelphi Laboratory Center), Sarette T. Tilton(Sanofi (United States))
Cited by 9
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
|Journal of Allergy and Clinical Immunology|2017|675
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
The atopic march and atopic multimorbidity: Many trajectories, many pathways
|Journal of Allergy and Clinical Immunology|2018|427